![Catherine Mazzacco](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Mazzacco
Direktor/Vorstandsmitglied bei
KRYSTAL BIOTECH, INC.
Vermögen: 319 560 $ am 31.05.2026
Profil
Catherine Mazzacco is currently Independent Director at Sight Sciences, Inc. since 2023, Director at LEO Laboratories Ltd. since 2019, Independent Director at Krystal Biotech, Inc. since 2023, Independent Member-Supervisory Board at Les Laboratoires Servier SAS, and Member-Supervisory Board at Servier SAS since 2022.
Former roles include President, Chief Executive Officer & Director at LEO Pharma A from 2019 to 2021, Vice President-Global Commercial Operations at Abbott Laboratories from 2011 to 2017, and Senior Vice President-Global Commercial Operations at GE Healthcare, Inc. from 2018 to 2019.
Education includes undergraduate studies at the University of Compiègne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SIGHT SCIENCES, INC. 0.12% | 04.06.2026 | 65’753 ( 0.12% ) | 319 560 $ | 31.05.2026 |
| 23.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Catherine Mazzacco
| Unternehmen | Position | Beginn |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Direktor/Vorstandsmitglied | 06.03.2023 |
| SIGHT SCIENCES, INC. | Direktor/Vorstandsmitglied | 08.06.2023 |
LEO Laboratories Ltd.
 LEO Laboratories Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical goods | Direktor/Vorstandsmitglied | 16.09.2019 |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for treatment of cancer, metabolism and neurology | Direktor/Vorstandsmitglied | - |
Servier SAS
 Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Direktor/Vorstandsmitglied | 01.02.2022 |
Ehemalige bekannte Positionen von Catherine Mazzacco
| Unternehmen | Position | Ende |
|---|---|---|
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Vorstandsvorsitzender | 01.11.2021 |
GE Healthcare, Inc.
 GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Corporate Officer/Principal | 01.05.2019 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Catherine Mazzacco
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Sight Sciences, Inc.
 Sight Sciences, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for treatment of cancer, metabolism and neurology | Health Technology |
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
LEO Laboratories Ltd.
LEO Laboratories Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical goods | Distribution Services |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Health Technology |
University of Compiègne
 University of Compiègne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
